Position in BTAI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1
+$0 QoQ
Shares Held
1
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 40 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BTAI Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026US BANCORP \DE\ holds $39,051,582 across 40 Drug Manufacturers - Specialty & Generic names. BTAI ranks #40 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
510,225 | $9,449,366 | |
| 2 | ZTS |
Zoetis Inc.
|
63,950 | $7,559,527 | |
| 3 | HLN |
Haleon plc
|
704,468 | $7,051,722 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
181,965 | $5,480,785 | |
| 5 | VTRS |
Viatris Inc
|
243,816 | $3,293,953 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
|
146,928 | $2,034,952 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
41,990 | $1,004,820 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
1,578 | $935,721 |
All Filings in BTAI
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1 | 1 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1 | 1 | Shares | Defined | 2026-01-30 | |
| 2025-09-30 | $2 | 1 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1 | 1 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $2 | 1 | Shares | Defined | 2025-05-08 | |
| No filing history on record for this holder in this stock. | ||||||